Boston Convention and Exhibition Center Room 254&255
415 Summer St, Boston, MA 02210
Simcere Innovation Inc. located in Cambridge, MA focuses on the research and development of life-changing therapies for our patients by utilizing cutting-edge technology, including cell and gene therapy. Simcere Innovation provides a remarkably unique model referred to as “internal entrepreneurship”. This model combines research and development with open innovation between partnerships in an effective and creative fashion that fosters growth and success.
Simcere Innovation is currently looking for outstanding scientists who aspire to become entrepreneurs with creative ideas and business plans. The internal entrepreneur will serve as an “internal startup founder” responsible for leading his/her team to successfully complete various projects, while Simcere Innovation provides funding, infrastructure and other resources that are necessary for the completion of ongoing projects. Simcere Innovation is a company of Simcere Pharmaceutical group, which is a fully-integrated pharmaceutical company with a mission to “Making Better Medicines Available to Patients Sooner.” Simcere Pharmaceutical group has over 50 products on the market with three R&D centers, four GMP facilities, and three oversea branches located in the United States of America, Europe and Hong Kong with over 5000 employees worldwide. Simcere has achieved 30% Compound Annual Growth Rate in four consecutive years.
Join other biotech executives for an evening of informational talks, wine and networking. This event is open to everyone! Registration is free! Complimentary drinks and refreshments are provided.
Date/Time: September 10th 4:00 p.m.- 7:00 p.m.
Address: Boston Convention and Exhibition Center, Room 254&255, 415 Summer St., Boston, MA 02210.
|255||4:00 PM- 4:20 PM||Special Talk “Understanding and curing rare diseases worldwide”
Harvey Lodish, Ph.D., Founding Member and Professor, Whitehead Institute for Biomedical Research/MIT
|4:20 PM- 4:40 PM||Special Talk “PD-1 Cancer Immunotherapy”
Gordon J. Freeman, Ph.D.- Professor of Medicine, Harvard Medical School
|4:40 PM- 5:00 PM||Special Talk “The Drug Regulatory Reform and Accelerating New Drug Development in China”
Z. Alex Xu, M.D., Ph.D. – Chief Scientist, CFDA/CDE
|5:00 PM-5:10 PM||“Simcere Innovation in Boston”
Shawn Xu-Executive Director, Simcere Innovation, Inc.
|254A&B||5:20 PM-7:00 PM||Networking|
Harvey F. Lodish, Ph.D.
Founding Member and Professor, Whitehead Institute for Biomedical Research/MIT
Gordon J. Freeman, Ph.D.
Professor of Medicine, Harvard Medical School
Z. Alex Xu, M.D., Ph.D.
Chief Scientist, CFDA/CDE
Shawn Xu, Ph.D.
Executive Director, Simcere Innovation, Inc.